This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gerena, L Articles by Martin, R K Search for Related Content PubMed PubMed Citation Articles by Gerena, L Articles by Martin, R K

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1992 December; 36(12): 2761-2765

Fluoxetine hydrochloride enhances in vitro susceptibility to chloroquine in resistant Plasmodium falciparum.

L Gerena, G T Bass Sr, D E Kyle, A M Oduola, W K Milhous and R K Martin

Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Washington, DC 20307-5100.

ABSTRACT

The emergence of chloroquine resistance in Plasmodium falciparum has necessitated the development of alternate strategies for chemotherapy and chemoprophylaxis. One approach has been the identification of drugs that do not possess any intrinsic antimalarial activity when used alone but that potentiate the effect of currently available antimalarial drugs, such as chloroquine. We identified fluoxetine hydrochloride (Prozac), a commonly prescribed antidepressant, as another resistance modulator for drug-resistant P. falciparum. Studies with chloroquine-resistant clones and isolates from various geographical locations confirmed our initial observations with a chloroquine-resistant P. falciparum clone, W2. Fluoxetine concentrations of 500 nM were found to effectively modulate chloroquine resistance by 66% in clone W2. In comparison, verapamil at similar concentrations was observed to modulate chloroquine resistance in clone W2 by 61%. Neither fluoxetine nor verapamil was observed to possess any innate antimalarial activity. These data augment the current description of the chloroquine resistance phenotype and may provide additional insights into lead-directed synthesis of new antimalarial drugs.

---

Antimicrob Agents Chemother. 1992 December; 36(12): 2761-2765

This article has been cited by other articles:

• Pradines, B., Alibert, S., Houdoin, C., Santelli-Rouvier, C., Mosnier, J., Fusai, T., Rogier, C., Barbe, J., Parzy, D. (2002). In Vitro Increase in Chloroquine Accumulation Induced by Dihydroethano- and Ethenoanthracene Derivatives in Plasmodium falciparum-Parasitized Erythrocytes. Antimicrob. Agents Chemother. 46: 2061-2068 [Abstract] [Full Text]  
• Taylor, D., Walden, J. C., Robins, A. H., Smith, P. J. (2000). Role of the Neurotransmitter Reuptake-Blocking Activity of Antidepressants in Reversing Chloroquine Resistance In Vitro in Plasmodium falciparum. Antimicrob. Agents Chemother. 44: 2689-2692 [Abstract] [Full Text]  
• Evans, S. G., Butkow, N., Stilwell, C., Berk, M., Kirchmann, N., Havlik, I. (1998). Citalopram Enhances the Activity of Chloroquine in Resistant Plasmodium in Vitro and in Vivo. J. Pharmacol. Exp. Ther. 286: 172-174 [Abstract] [Full Text]